BONESUPPORT HOLDING AB ( (SE:BONEX) ) has shared an announcement.
BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO after 7.5 years to become a Senior Advisor, while Torbjörn Sköld will take over as CEO on September 1, 2025. Sköld brings extensive experience in the MedTech sector, with a strong background in surgery and orthopedics, and is expected to drive the company forward in its mission to innovate and grow in the orthobiologics market. This change is seen as a strategic move to maintain the company’s growth trajectory and strengthen its market position.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a leading company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have the capability of eluting drugs. The company is based in Lund, Sweden, and has a strong market presence with net sales amounting to SEK 899 million in 2024.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
Find detailed analytics on BONEX stock on TipRanks’ Stock Analysis page.